Cannabis While Breastfeeding

Cannabis While Breastfeeding: What the Science Shows

An evidence-based look at THC in breast milk, infant risks, and what nursing parents need to know.

What Is "Cannabis While Breastfeeding"?

The phrase "cannabis while breastfeeding" describes the practice — intentional or otherwise — of using cannabis products (smoked, vaped, edible, or topical) while actively nursing an infant. It is a topic that sits at the crossroads of public health, addiction medicine, pediatric neurology, and the rapidly evolving landscape of cannabis legalization in the United States.

Historically, discussions about cannabis use during pregnancy and the postpartum period were largely anecdotal or driven by stigma rather than science. As cannabis has become legal for adult recreational use in more than two dozen states, and as more people report using it to manage conditions like anxiety, chronic pain, insomnia, and postpartum depression, the medical community has had to respond with more rigorous research. The challenge is significant: ethical constraints prevent researchers from conducting controlled experiments on nursing infants, so most data comes from observational studies, animal models, and breast milk analysis.

Today, major health organizations — including the Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP), and the Food and Drug Administration (FDA) — uniformly advise against any cannabis use during breastfeeding. This consensus is grounded in what is known about how THC and other cannabinoids behave in the body, how breast milk is formed, and how infant neurodevelopment can be disrupted. To understand why their guidance is so clear, it helps to look at the underlying science.

Explore more foundational topics in our cannabis explainers hub, or read about how cannabis affects the human body in general.

How It Works: The Science of THC in Breast Milk

To understand why cannabis use during breastfeeding is a medical concern, you need to understand two things: how THC behaves chemically, and how breast milk is produced.

THC's fat-solubility is the core issue. Delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, is highly lipophilic — meaning it binds readily to fats and fatty tissues. Breast milk is naturally rich in fat (lipids), which serve as the primary caloric and developmental nutrient for infants. Because of this fat affinity, THC does not simply pass through milk in proportion to blood levels. Instead, it concentrates in the fat globules of milk at roughly 8 times the concentration found in maternal blood plasma. This is a critical distinction: a nursing parent with modest blood THC levels can still pass a significant dose of THC to their infant through milk.

Think of it like this: imagine your bloodstream is a glass of water with a few drops of oil floating on top. Your breast milk is a glass of cream — mostly fat. If you pour both glasses into a separator, the oil (THC) will move almost entirely into the cream. That cream is what your baby drinks.

The infant's underdeveloped metabolism compounds the risk. Adults have mature liver enzyme systems (particularly CYP450 enzymes) that break down THC relatively efficiently. Newborns and young infants have significantly less enzymatic capacity, meaning THC and its active metabolite (11-hydroxy-THC) linger in their systems far longer than they would in an adult. Their blood-brain barrier is also less developed, allowing more psychoactive substances to reach the brain.

The endocannabinoid system is actively developing. The endocannabinoid system (ECS) — the network of receptors (CB1 and CB2) that THC hijacks to produce its effects — plays a crucial role in fetal and infant brain development. CB1 receptors guide neuron migration, synapse formation, and cortical organization. Introducing exogenous cannabinoids (from cannabis) during this window can disrupt these processes in ways that may not manifest clinically until months or years later.

Learn more about how the ECS works in our explainers section, and explore the effects of cannabinoids on different body systems.

Key Data & Research

Scientific literature on cannabis and breastfeeding has grown substantially in the past decade, though it remains limited compared to research on alcohol or tobacco. Here is a summary of the most important findings:

It is worth noting that research methodology presents real challenges in this field. Most studies are observational, meaning researchers cannot randomly assign nursing parents to use or abstain from cannabis. Confounding variables — poverty, other substance use, stress, diet — are difficult to fully control for. Cannabis potency has also increased dramatically over the past 20 years (modern flower often contains 20–30% THC compared to 3–4% in the 1980s), meaning older studies may underestimate current risks. For context on how THC potency has evolved, see our guide to cannabis strains.

"There is no known safe amount of marijuana use during pregnancy or while breastfeeding. THC is stored in body fat and can be slowly released over time, meaning a baby could be exposed to marijuana for weeks or months after you stop using it."

— Centers for Disease Control and Prevention (CDC)

Practical Implications for Cannabis Consumers

For adults who use cannabis recreationally or medically, the arrival of a new baby — and the decision to breastfeed — creates an immediate and non-negotiable conflict with continued cannabis use, according to all major pediatric and public health bodies. Here is what the evidence means in practical terms: